“Decreased BDNF levels in amygdala and hippocampus after intracerebroventricular administration of ouabain”, Arch Clin Psychiatry (former: Rev Psiq Clin), vol. 39, no. 5, pp. 157–160, Jan. 2012, doi: 10.1590/S0101-60832012000500002.